Deutsch
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

premature ejaculation/übelkeit

Der Link wird in der Zwischenablage gespeichert
ArtikelKlinische VersuchePatente
Seite 1 von 34 Ergebnisse

Comparison of the efficacy and safety of 90 mg versus 20 mg fluoxetine in the treatment of premature ejaculation.

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
OBJECTIVE We compare the efficacy and side effects of 90 mg fluoxetine once weekly versus 20 mg fluoxetine as single oral therapy for patients complaining of premature ejaculation without evident organic causes. METHODS The study comprised 80 patients with a mean age of 36 years with premature

Dapoxetine for premature ejaculation.

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
BACKGROUND Premature ejaculation (PE) is a common male sexual disorder which is associated with substantial personal and interpersonal negative psychological factors. Drug treatment of PE with an off-label antidepressant selective serotonin reuptake inhibitor (SSRI) drug is common. The lack of an

Efficacy of dapoxetine in the treatment of premature ejaculation.

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
BACKGROUND Premature ejaculation (PE) is a common male sexual disorder which is associated with substantial personal and interpersonal negative psychological factors. Pharmacotherapy of PE with off-label antidepressant SSRI drugs is common. Development and regulatory approval of drugs specifically

Dapoxetine: a new option in the medical management of premature ejaculation.

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
Premature ejaculation (PE) is a common male sexual disorder which is associated with substantial personal and interpersonal negative psychological consequences. Pharmacotherapy of PE with off-label antidepressant selective serotonin reuptake inhibitors (SSRIs) is common, effective and safe.
In this study, we aimed at evaluating the efficacy and safety of venlafaxine extended release 75 mg, a serotonin and noradrenaline reuptake inhibitor, in the treatment of patients with premature ejaculation. Thirty-one patients with intravaginal ejaculation latency of less than 2 min received

A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation.

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
OBJECTIVE We compared the efficacy of paroxetine alone and combined with sildenafil in patients complaining of premature ejaculation. METHODS Enrolled in this study were 80 consecutive potent men 19 to 47 years old (mean age 34) with premature ejaculation but without any obvious organic cause.
OBJECTIVE To assess the utility of perceived control over ejaculation ('control') in the evaluation of treatment benefit in men with premature ejaculation (PE), and to compare effects associated with a two-category or greater increase in this variable between men receiving dapoxetine and

Treatment benefit of dapoxetine for premature ejaculation: results from a placebo-controlled phase III trial.

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
OBJECTIVE To evaluate the overall treatment benefit of dapoxetine for premature ejaculation (PE), with specific emphasis on improvements in personal distress and interpersonal difficulty related to ejaculation. Although these factors are key elements of numerous sets of diagnostic criteria for PE,
OBJECTIVE In the present study, two different serotonin re-uptake inhibitors were compared with regard to their efficacy and side effects in the treatment of premature ejaculation. METHODS Fifty-seven patients with complaint of premature ejaculation were included in the study. Patient ages ranged

[Dapoxetine for premature ejaculation: Advances in clinical studies].

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
Premature ejaculation (PE) is a most common sexual dysfunction, for which dapoxetine, a novel selective serotonin (5-HT) re-uptake inhibitor (SSRI), is the only licensed oral medicine at present. With the advantages of fast absorption, rapid action, on-demand medication, and short half-life time,

The efficacy of fluoxetine in the treatment of premature ejaculation: a double-blind placebo controlled study.

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
OBJECTIVE The efficacy of the selective serotonin re-uptake inhibitor fluoxetine in the treatment of premature ejaculation was examined. METHODS The study comprised 17 patients with premature ejaculation who presented to the urology clinic of our medical school. In this double-blind study the

Tramadol for premature ejaculation: a systematic review and meta-analysis.

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
BACKGROUND Tramadol is a centrally acting analgesic prescribed off-label for the treatment of premature ejaculation (PE). However, tramadol may cause addiction and difficulty in breathing and the beneficial effect of tramadol in PE is yet not supported by a high level of evidence. The purpose of

Emerging treatments for premature ejaculation: focus on dapoxetine.

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
Premature ejaculation (PE) is a common problem in men worldwide. It has a significant impact on affected men and their partners in terms of self-esteem, dissatisfaction with their sexual relationships, personal distress, and interpersonal difficulty. Psychological therapies may achieve short-term

Current and future pharmacotherapies of premature ejaculation.

Nur registrierte Benutzer können Artikel übersetzen
Einloggen Anmelden
BACKGROUND There are currently no oral or topical agents approved by government regulation agencies for the management of premature ejaculation (PE). OBJECTIVE To review pharmacologic therapies for treatment of PE. METHODS The Sexual Medicine Society of North America hosted a State of the Art
BACKGROUND No drugs are approved for treatment of premature ejaculation. Our aim was to determine the efficacy and tolerability of on-demand dapoxetine in patients with severe premature ejaculation. METHODS We determined the efficacy of dapoxetine in a prospectively predefined integrated analysis of
Treten Sie unserer
Facebook-Seite bei

Die vollständigste Datenbank für Heilkräuter, die von der Wissenschaft unterstützt wird

  • Arbeitet in 55 Sprachen
  • Von der Wissenschaft unterstützte Kräuterkuren
  • Kräutererkennung durch Bild
  • Interaktive GPS-Karte - Kräuter vor Ort markieren (in Kürze)
  • Lesen Sie wissenschaftliche Veröffentlichungen zu Ihrer Suche
  • Suchen Sie nach Heilkräutern nach ihrer Wirkung
  • Organisieren Sie Ihre Interessen und bleiben Sie über Neuigkeiten, klinische Studien und Patente auf dem Laufenden

Geben Sie ein Symptom oder eine Krankheit ein und lesen Sie über Kräuter, die helfen könnten, geben Sie ein Kraut ein und sehen Sie Krankheiten und Symptome, gegen die es angewendet wird.
* Alle Informationen basieren auf veröffentlichten wissenschaftlichen Forschungsergebnissen

Google Play badgeApp Store badge